38 related articles for article (PubMed ID: 6129395)
1. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.
Metz DC; Pisegna JR; Ringham GL; Feigenbaum K; Koviack PD; Maton PN; Gardner JD; Jensen RT
Dig Dis Sci; 1993 Feb; 38(2):245-56. PubMed ID: 8425437
[TBL] [Abstract][Full Text] [Related]
3. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
Howden CW; Forrest JA; Reid JL
Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
[TBL] [Abstract][Full Text] [Related]
4. Effects of single daily doses of a pyridil-2-tetrahydrothiophene derivative (40749 RP) on 24 hour H+ activity, nocturnal acid output, gastrin and pepsinogen I profiles in duodenal ulcer patients.
Malè PJ; Griessen M; Cunningham MG; Frydman AM; Garoflid-Oprescu NA; De Peyer R; Loizeau E
Gut; 1986 Apr; 27(4):423-7. PubMed ID: 3957110
[TBL] [Abstract][Full Text] [Related]
5. Influence of chronic omeprazole treatment on gastric endocrine function.
Koop H; Schwarting H; Knorr-Marin A; Willhardt C; Möser T; Arnold R
Klin Wochenschr; 1987 Feb; 65(4):169-73. PubMed ID: 2882060
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of omeprazole.
Howden CW
Clin Pharmacokinet; 1991 Jan; 20(1):38-49. PubMed ID: 2029801
[TBL] [Abstract][Full Text] [Related]
7. Use of omeprazole in patients with Zollinger-Ellison syndrome.
Frucht H; Maton PN; Jensen RT
Dig Dis Sci; 1991 Apr; 36(4):394-404. PubMed ID: 2007355
[TBL] [Abstract][Full Text] [Related]
8. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
Sosnowski M
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
[No Abstract] [Full Text] [Related]
9. Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole.
Oberg K; Lindström H
Lancet; 1983 Jan; 1(8314-5):66-7. PubMed ID: 6129395
[No Abstract] [Full Text] [Related]
10. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
11. [Omeprazole, the drug of the future for the treatment of Zollinger-Ellison syndrome and duodenal ulcer?].
Fiasse R; Tomé G; Dive C
Acta Gastroenterol Belg; 1984; 47(6):555-68. PubMed ID: 6537111
[No Abstract] [Full Text] [Related]
12. [Gastric secretory, ultrastructural and pH changes during prolonged treatment with omeprazole in a severe form of Zollinger-Ellison syndrome].
Mignon M; Alcabes G; Lehy T; Nguyen Phuoc BK; Vatier J; Bonfils S
Gastroenterol Clin Biol; 1984 Dec; 8(12):947-54. PubMed ID: 6519403
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole in the Zollinger-Ellison syndrome.
Bardram L; Stadil F
Scand J Gastroenterol; 1986 Apr; 21(3):374-8. PubMed ID: 3715402
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
